{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T16:33:55Z","timestamp":1780590835694,"version":"3.54.1"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100012021","name":"Iran University of Medical Sciences","doi-asserted-by":"publisher","award":["IR.IUMS.FMD.REC.1399.624"],"award-info":[{"award-number":["IR.IUMS.FMD.REC.1399.624"]}],"id":[{"id":"10.13039\/100012021","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.intimp.2021.107684","type":"journal-article","created":{"date-parts":[[2021,4,19]],"date-time":"2021-04-19T03:22:21Z","timestamp":1618802541000},"page":"107684","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"special_numbering":"C","title":["A possible pathogenic role of Syndecan-1 in the pathogenesis of coronavirus disease 2019 (COVID-19)"],"prefix":"10.1016","volume":"97","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3716-8096","authenticated-orcid":false,"given":"Sajad","family":"Karampoor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Zahednasab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Farahmand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasoul","family":"Mirzaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhad","family":"Zamani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Tabibzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behnaz","family":"Bouzari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Ajdarkosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Nikkhah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melika Razavi","family":"Hashemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azadeh","family":"Laali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Keyvani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.intimp.2021.107684_b0005","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00441-009-0829-3","article-title":"Syndecans as receptors and organizers of the extracellular matrix","volume":"339","author":"Xian","year":"2010","journal-title":"Cell Tissue Res."},{"issue":"19","key":"10.1016\/j.intimp.2021.107684_b0010","doi-asserted-by":"crossref","first-page":"14247","DOI":"10.1074\/jbc.M109.056945","article-title":"Heparan sulfate chain valency controls syndecan-4 function in cell adhesion","volume":"285","author":"Gopal","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"13","key":"10.1016\/j.intimp.2021.107684_b0015","doi-asserted-by":"crossref","first-page":"8133","DOI":"10.1074\/jbc.272.13.8133","article-title":"Syndecan-4 proteoglycan regulates the distribution and activity of protein kinase C","volume":"272","author":"Oh","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"17","key":"10.1016\/j.intimp.2021.107684_b0020","doi-asserted-by":"crossref","first-page":"10624","DOI":"10.1074\/jbc.273.17.10624","article-title":"Syndecan-4 proteoglycan cytoplasmic domain and phosphatidylinositol 4, 5-bisphosphate coordinately regulate protein kinase C activity","volume":"273","author":"Oh","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"21","key":"10.1016\/j.intimp.2021.107684_b0025","doi-asserted-by":"crossref","first-page":"4788","DOI":"10.1242\/jcs.153015","article-title":"Shed syndecan-2 inhibits angiogenesis","volume":"127","author":"De Rossi","year":"2014","journal-title":"J. Cell Sci."},{"issue":"6","key":"10.1016\/j.intimp.2021.107684_b0030","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1042\/BST20140232","article-title":"Syndecans in angiogenesis and endothelial cell biology","volume":"42","author":"De Rossi","year":"2014","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.intimp.2021.107684_b0035","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3389\/fimmu.2020.00227","article-title":"Syndecans in inflammation at a glance","volume":"11","author":"Gopal","year":"2020","journal-title":"Front. Immunol."},{"issue":"24","key":"10.1016\/j.intimp.2021.107684_b0040","doi-asserted-by":"crossref","first-page":"12714","DOI":"10.1128\/JVI.00717-09","article-title":"Heparan sulfate proteoglycans are required for cellular binding of the hepatitis E virus ORF2 capsid protein and for viral infection","volume":"83","author":"Kalia","year":"2009","journal-title":"J. Virol."},{"issue":"Pt 4","key":"10.1016\/j.intimp.2021.107684_b0045","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1099\/vir.0.027052-0","article-title":"Syndecan-1 and syndecan-2 play key roles in herpes simplex virus type-1 infection","volume":"92","author":"Bacsa","year":"2011","journal-title":"J. Gen. Virol."},{"issue":"5","key":"10.1016\/j.intimp.2021.107684_b0050","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.1074\/jbc.M110.185165","article-title":"Syndecan-1 promotes Staphylococcus aureus corneal infection by counteracting neutrophil-mediated host defense","volume":"286","author":"Hayashida","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2021.107684_b0055","doi-asserted-by":"crossref","unstructured":"E. Freissler, A. Meyer auf der Heyde, G. David, T.F. Meyer, C. Dehio, Syndecan\u20101 and syndecan\u20104 can mediate the invasion of OpaHSPG\u2010expressing Neisseria gonorrhoeae into epithelial cells, Cellular Microbio. 2(1) (2000) 69\u201382.","DOI":"10.1046\/j.1462-5822.2000.00036.x"},{"issue":"1","key":"10.1016\/j.intimp.2021.107684_b0060","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.matbio.2011.10.001","article-title":"Molecular functions of syndecan-1 in disease","volume":"31","author":"Teng","year":"2012","journal-title":"Matrix Biol."},{"key":"10.1016\/j.intimp.2021.107684_b0065","doi-asserted-by":"crossref","unstructured":"P. Goodarzi, F. Mahdavi, R. Mirzaei, H. Hasanvand, M. Sholeh, F. Zamani, M. Sohrabi, A. Tabibzadeh, A.S. Jeda, M.H.K. Niya, Coronavirus disease 2019 (COVID-19): Immunological approaches and emerging pharmacologic treatments, Int. Immunopharmacol. (2020) 106885.","DOI":"10.1016\/j.intimp.2020.106885"},{"issue":"18","key":"10.1016\/j.intimp.2021.107684_b0070","first-page":"1824","article-title":"Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review","volume":"323","author":"Sanders","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.intimp.2021.107684_b0075","doi-asserted-by":"crossref","first-page":"106928","DOI":"10.1016\/j.intimp.2020.106928","article-title":"Overview of the current promising approaches for the development of an effective severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine","author":"Mirzaei","year":"2020","journal-title":"Int. Immunopharmacol."},{"issue":"5","key":"10.1016\/j.intimp.2021.107684_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105951","article-title":"Coronavirus disease 2019 (COVID-19): current status and future perspectives","volume":"55","author":"Li","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"7","key":"10.1016\/j.intimp.2021.107684_b0085","doi-asserted-by":"crossref","first-page":"5365","DOI":"10.1007\/s11033-020-05621-1","article-title":"A contemporary review on pathogenesis and immunity of COVID-19 infection","volume":"47","author":"Mirzaei","year":"2020","journal-title":"Mol. Biol. Rep."},{"issue":"10223","key":"10.1016\/j.intimp.2021.107684_b0090","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan","volume":"395","author":"Huang","year":"2020","journal-title":"China, The lancet"},{"issue":"1","key":"10.1016\/j.intimp.2021.107684_b0095","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/jebm.12376","article-title":"Preliminary prediction of the basic reproduction number of the Wuhan novel coronavirus 2019-nCoV","volume":"13","author":"Zhou","year":"2020","journal-title":"J. Evidence-Based Med."},{"key":"10.1016\/j.intimp.2021.107684_b0100","doi-asserted-by":"crossref","unstructured":"N. Zhu, D. Zhang, W. Wang, X. Li, B. Yang, J. Song, X. Zhao, B. Huang, W. Shi, R. Lu, A novel coronavirus from patients with pneumonia in China, 2019, New Engl. J. Med. (2020).","DOI":"10.1056\/NEJMoa2001017"},{"issue":"1","key":"10.1016\/j.intimp.2021.107684_b0105","first-page":"1","article-title":"Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review","volume":"9","author":"Adhikari","year":"2020","journal-title":"Infectious Dis. Poverty"},{"issue":"5","key":"10.1016\/j.intimp.2021.107684_b0110","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/jmv.25711","article-title":"The course of clinical diagnosis and treatment of a case infected with coronavirus disease 2019","volume":"92","author":"Han","year":"2020","journal-title":"J. Med. Virol."},{"issue":"6","key":"10.1016\/j.intimp.2021.107684_b0115","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.jinf.2020.03.035","article-title":"Serum Amyloid A is a biomarker of severe Coronavirus Disease and poor prognosis","volume":"80","author":"Li","year":"2020","journal-title":"J. Infect."},{"key":"10.1016\/j.intimp.2021.107684_b0120","doi-asserted-by":"crossref","unstructured":"D.D. Fraser, E.K. Patterson, M. Slessarev, S.E. Gill, C. Martin, M. Daley, M.R. Miller, M.A. Patel, C.C. Dos Santos, K.J. Bosma, Endothelial injury and glycocalyx degradation in critically ill coronavirus disease 2019 patients: Implications for microvascular platelet aggregation, Critical care Explorations 2(9) (2020).","DOI":"10.1097\/CCE.0000000000000194"},{"issue":"1","key":"10.1016\/j.intimp.2021.107684_b0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12959-021-00258-x","article-title":"Possible involvement of Syndecan-1 in the state of COVID-19 related to endothelial injury","volume":"19","author":"Suzuki","year":"2021","journal-title":"Thrombosis J."},{"issue":"6","key":"10.1016\/j.intimp.2021.107684_b0130","article-title":"Inflammation profiling of critically ill coronavirus disease 2019 patients","volume":"2","author":"Fraser","year":"2020","journal-title":"Crit. Care Explor."},{"key":"10.1016\/j.intimp.2021.107684_b0135","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jneuroim.2015.11.017","article-title":"25-hydroxyvitamin D levels are associated with multiple sclerosis in Iran: A cross-sectional study","volume":"290","author":"Karampoor","year":"2016","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.intimp.2021.107684_b0140","first-page":"1","article-title":"Characteristics of SARS-CoV-2 and COVID-19","author":"Hu","year":"2020","journal-title":"Nat. Rev. Microbiol."},{"issue":"10","key":"10.1016\/j.intimp.2021.107684_b0145","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1002\/iub.2356","article-title":"Bacterial co-infections with SARS-CoV-2","volume":"72","author":"Mirzaei","year":"2020","journal-title":"IUBMB Life"},{"key":"10.1016\/j.intimp.2021.107684_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.107204","article-title":"The emerging role of microRNAs in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection","volume":"90","author":"Mirzaei","year":"2021","journal-title":"Int. Immunopharmacol."},{"issue":"24","key":"10.1016\/j.intimp.2021.107684_b0155","doi-asserted-by":"crossref","first-page":"13125","DOI":"10.1128\/JVI.77.24.13125-13135.2003","article-title":"Different heparan sulfate proteoglycans serve as cellular receptors for human papillomaviruses","volume":"77","author":"Shafti-Keramat","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.intimp.2021.107684_b0160","doi-asserted-by":"crossref","unstructured":"A. Ceballos, F. Remes Lenicov, J. Sabatt\u00e9, C. Rodr\u00edguez Rodr\u00edgues, M. Cabrini, C. Jancic, S. Raiden, M. Donaldson, R. Agust\u00edn Pasqualini Jr, C. Marin-Briggiler, Spermatozoa capture HIV-1 through heparan sulfate and efficiently transmit the virus to dendritic cells, J. Exp. Med. 206(12) (2009) 2717\u20132733.","DOI":"10.1084\/jem.20091579"},{"issue":"19","key":"10.1016\/j.intimp.2021.107684_b0165","doi-asserted-by":"crossref","first-page":"9187","DOI":"10.1128\/JVI.75.19.9187-9200.2001","article-title":"Syndecans serve as attachment receptors for human immunodeficiency virus type 1 on macrophages","volume":"75","author":"Saphire","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.intimp.2021.107684_b0170","doi-asserted-by":"crossref","unstructured":"A.J. Smith, T.W. Schacker, C.S. Reilly, A.T. Haase, A role for syndecan-1 and claudin-2 in microbial translocation during HIV-1 infection, Journal of acquired immune deficiency syndromes (1999) 55(3) (2010) 306.","DOI":"10.1097\/QAI.0b013e3181ecfeca"},{"issue":"8","key":"10.1016\/j.intimp.2021.107684_b0175","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0300-9084(01)01290-1","article-title":"Heparan sulfate: anchor for viral intruders?","volume":"83","author":"Spillmann","year":"2001","journal-title":"Biochimie"},{"key":"10.1016\/j.intimp.2021.107684_b0180","doi-asserted-by":"crossref","DOI":"10.1017\/S1462399409001367","article-title":"Proteoglycans in host\u2013pathogen interactions: molecular mechanisms and therapeutic implications","volume":"12","author":"Bartlett","year":"2010","journal-title":"Expert Rev. Mol. Med."},{"key":"10.1016\/j.intimp.2021.107684_b0185","article-title":"SARS-CoV-2 infection and transmission depends on heparan sulfates and is blocked by low molecular weight heparins","author":"Bermejo-Jambrina","year":"2020","journal-title":"BioRxiv"},{"key":"10.1016\/j.intimp.2021.107684_b0190","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.00749","article-title":"The role of proteoglycans in cancer metastasis and circulating tumor cell analysis","volume":"8","author":"Ahrens","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.intimp.2021.107684_b0195","doi-asserted-by":"crossref","unstructured":"S. Reitsma, D.W. Slaaf, H. Vink, M.A. Van Zandvoort, M.G. oude Egbrink, The endothelial glycocalyx: composition, functions, and visualization, Pfl\u00fcgers Archiv-Eur. J. Physiol. 454(3) (2007) 345\u2013359.","DOI":"10.1007\/s00424-007-0212-8"},{"issue":"5","key":"10.1016\/j.intimp.2021.107684_b0200","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s004240000307","article-title":"The endothelial surface layer","volume":"440","author":"Pries","year":"2000","journal-title":"Pfl\u00fcgers Archiv."},{"issue":"1","key":"10.1016\/j.intimp.2021.107684_b0205","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/aas.12223","article-title":"Circulating glycosaminoglycan species in septic shock","volume":"58","author":"Nelson","year":"2014","journal-title":"Acta Anaesthesiol. Scand."},{"key":"10.1016\/j.intimp.2021.107684_b0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.mvr.2019.103971","article-title":"Sublingual microvasculature in diabetic patients","volume":"129","author":"Wadowski","year":"2020","journal-title":"Microvasc. Res."},{"issue":"4","key":"10.1016\/j.intimp.2021.107684_b0215","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/path.3964","article-title":"Endothelial glycocalyx dysfunction in disease: albuminuria and increased microvascular permeability","volume":"226","author":"Salmon","year":"2012","journal-title":"J. Pathol."},{"issue":"4","key":"10.1016\/j.intimp.2021.107684_b0220","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1164\/rccm.201511-2281OC","article-title":"Urinary glycosaminoglycans predict outcomes in septic shock and acute respiratory distress syndrome","volume":"194","author":"Schmidt","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"3","key":"10.1016\/j.intimp.2021.107684_b0225","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1177\/0310057X20916471","article-title":"Decreased endothelial glycocalyx thickness is an early predictor of mortality in sepsis","volume":"48","author":"Beurskens","year":"2020","journal-title":"Anaesth. Intensive Care"},{"issue":"6","key":"10.1016\/j.intimp.2021.107684_b0230","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/01.shk.0000184286.95493.78","article-title":"Ability of the heparan sulfate proteoglycan syndecan-1 to participate in bacterial translocation across the intestinal epithelial barrier","volume":"24","author":"Henry-Stanley","year":"2005","journal-title":"Shock"},{"key":"10.1016\/j.intimp.2021.107684_b0235","article-title":"COVID-19 cytokine storm: targeting the appropriate cytokine, The Lancet","author":"Cron","year":"2021","journal-title":"Rheumatology"},{"key":"10.1016\/j.intimp.2021.107684_b0240","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.3389\/fimmu.2020.01441","article-title":"Immune response, inflammation, and the clinical spectrum of COVID-19","volume":"11","author":"Garc\u00eda","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2021.107684_b0245","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cytogfr.2020.05.003","article-title":"The cytokine storm in COVID-19: An overview of the involvement of the chemokine\/chemokine-receptor system","volume":"53","author":"Coperchini","year":"2020","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.intimp.2021.107684_b0250","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.3389\/fimmu.2020.01446","article-title":"The COVID-19 cytokine storm; what we know so far","volume":"11","author":"Ragab","year":"2020","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.intimp.2021.107684_b0255","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.200160","article-title":"Cytokine storm and COVID-19: a chronicle of pro-inflammatory cytokines","volume":"10","author":"Fara","year":"2020","journal-title":"Open Biol."},{"key":"10.1016\/j.intimp.2021.107684_b0260","article-title":"IL-6 and IL-10 as predictors of disease severity in COVID 19 patients: Results from Meta-analysis and Regression","author":"Dhar","year":"2020","journal-title":"MedRxiv"},{"key":"10.1016\/j.intimp.2021.107684_b0265","doi-asserted-by":"crossref","first-page":"110698","DOI":"10.1016\/j.biopha.2020.110698","article-title":"The role of Interleukin 6 inhibitors in therapy of severe COVID-19","author":"Nasonov","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.intimp.2021.107684_b0270","article-title":"Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort study, The Lancet","author":"Cavalli","year":"2021","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.intimp.2021.107684_b0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-020-02571-x","article-title":"Serum interleukin-6 is an indicator for severity in 901 patients with SARS-CoV-2 infection: a cohort study","volume":"18","author":"Zhang","year":"2020","journal-title":"J. Translational Med."},{"key":"10.1016\/j.intimp.2021.107684_b0280","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.molimm.2020.10.006","article-title":"High serum IL-6 values increase the risk of mortality and the severity of pneumonia in patients diagnosed with COVID-19","volume":"128","author":"Guirao","year":"2020","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.intimp.2021.107684_b0285","first-page":"e926941","article-title":"Serum Interleukin-6 Concentrations and the Severity of COVID-19 Pneumonia: A Retrospective Study at a Single Center in Bengbu City, Anhui Province, China, in January and February 2020","volume":"26","author":"Sun","year":"2020","journal-title":"Med. Sci. Monit. Int. Med. J. Exp. Clin. Res."},{"key":"10.1016\/j.intimp.2021.107684_b0290","article-title":"Prognostic value of interleukin-18 and its association with other inflammatory markers and disease severity in COVID-19","volume":"137","author":"Sat\u0131\u015f","year":"2020","journal-title":"Cytokine"},{"key":"10.1016\/j.intimp.2021.107684_b0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.medmic.2020.100023","article-title":"Analysis of the intestinal microbiota in COVID-19 patients and its correlation with the inflammatory factor IL-18","volume":"5","author":"Tao","year":"2020","journal-title":"Med. Microecol."},{"issue":"12","key":"10.1016\/j.intimp.2021.107684_b0300","doi-asserted-by":"crossref","DOI":"10.1038\/s41577-020-00467-x","article-title":"IL-18-dependent MAIT cell activation in COVID-19","volume":"20","author":"Gea-Mallorqu\u00ed","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2021.107684_b0305","doi-asserted-by":"crossref","first-page":"500","DOI":"10.5937\/jomb0-27554","article-title":"C-reactive protein as an early predictor of COVID-19 severity","volume":"39","author":"Ahnach","year":"2020","journal-title":"J. Med. Biochem."},{"issue":"16","key":"10.1016\/j.intimp.2021.107684_b0310","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1093\/cid\/ciaa641","article-title":"Prognostic value of C-reactive protein in patients with coronavirus 2019","volume":"71","author":"Luo","year":"2020","journal-title":"Clin. Infect. Dis."},{"issue":"4","key":"10.1016\/j.intimp.2021.107684_b0315","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.medmal.2020.03.007","article-title":"C-reactive protein levels in the early stage of COVID-19","volume":"50","author":"Wang","year":"2020","journal-title":"Medecine et maladies infectieuses"},{"issue":"1","key":"10.1016\/j.intimp.2021.107684_b0320","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1080\/22221751.2020.1770129","article-title":"Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors","volume":"9","author":"Han","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.intimp.2021.107684_b0325","article-title":"A Potential Role of Interleukin-10 in COVID-19 Pathogenesis","author":"Lu","year":"2020","journal-title":"Trends Immunol."},{"key":"10.1016\/j.intimp.2021.107684_b0330","doi-asserted-by":"crossref","unstructured":"J. Li, L. Rong, R. Cui, J. Feng, Y. Jin, Y. Yu, X. Chen, R. Xu, Dynamic changes in serum IL-6, IL-8, and IL-10 are associated with the outcome of patients with severe COVID-19 in ICU, (2020).","DOI":"10.21203\/rs.3.rs-83336\/v1"},{"issue":"1","key":"10.1016\/j.intimp.2021.107684_b0335","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-019-0089-y","article-title":"SARS-CoV-2 triggers inflammatory responses and cell death through caspase-8 activation","volume":"5","author":"Li","year":"2020","journal-title":"Signal Transduction Targeted Therapy"},{"issue":"9","key":"10.1016\/j.intimp.2021.107684_b0340","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1017\/S0950268814000193","article-title":"Does vitamin D protect against respiratory viral infections?","volume":"142","author":"Bryson","year":"2014","journal-title":"Epidemiol. Infect."},{"issue":"6","key":"10.1016\/j.intimp.2021.107684_b0345","first-page":"529","article-title":"Back to basics: review on vitamin D and respiratory viral infections including COVID-19","volume":"10","author":"Balla","year":"2020","journal-title":"J. Commun. Hospit. Int. Med. Perspect."},{"issue":"4","key":"10.1016\/j.intimp.2021.107684_b0350","doi-asserted-by":"crossref","first-page":"300","DOI":"10.4103\/0976-500X.103685","article-title":"Vitamin D for prevention of respiratory tract infections: A systematic review and meta-analysis","volume":"3","author":"Charan","year":"2012","journal-title":"J. Pharmacol. Pharmacotherapeutics"},{"issue":"1","key":"10.1016\/j.intimp.2021.107684_b0355","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-77093-z","article-title":"Analysis of vitamin D level among asymptomatic and critically ill COVID-19 patients and its correlation with inflammatory markers","volume":"10","author":"Jain","year":"2020","journal-title":"Sci. Rep."},{"issue":"17","key":"10.1016\/j.intimp.2021.107684_b0360","doi-asserted-by":"crossref","first-page":"3693","DOI":"10.1111\/febs.15495","article-title":"Low plasma 25 (OH) vitamin D level is associated with increased risk of COVID-19 infection: an Israeli population-based study","volume":"287","author":"Merzon","year":"2020","journal-title":"FEBS J."},{"key":"10.1016\/j.intimp.2021.107684_b0365","first-page":"1","article-title":"Vitamin D deficiency as a predictor of poor prognosis in patients with acute respiratory failure due to COVID-19","author":"Carpagnano","year":"2020","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.intimp.2021.107684_b0370","article-title":"Low serum 25-hydroxyvitamin D (25 [OH] D) levels in patients hospitalised with COVID-19 are associated with greater disease severity, 22nd European Congress of Endocrinology","author":"Tee","year":"2020","journal-title":"BioScientifica"},{"key":"10.1016\/j.intimp.2021.107684_b0375","doi-asserted-by":"crossref","DOI":"10.1002\/ccr3.4010","article-title":"Vitamin D and COVID-19 in an immunocompromised patient with multiple comorbidities\u2014A Case Report","author":"Kralj","year":"2021","journal-title":"Clin. Case Rep."},{"key":"10.1016\/j.intimp.2021.107684_b0380","doi-asserted-by":"crossref","unstructured":"E. The Lancet Diabetes, Vitamin D and COVID-19: why the controversy?, lancet. Diabetes Endocrinol. 9(2) (2021) 53.","DOI":"10.1016\/S2213-8587(21)00003-6"},{"key":"10.1016\/j.intimp.2021.107684_b0385","doi-asserted-by":"crossref","DOI":"10.1093\/qjmed\/hcab009","article-title":"Vitamin D supplementation, COVID-19 and disease severity: a meta-analysis","author":"Shah","year":"2021","journal-title":"QJM: Int. J. Med."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921003209?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921003209?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T04:50:41Z","timestamp":1778820641000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576921003209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":77,"alternative-id":["S1567576921003209"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2021.107684","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A possible pathogenic role of Syndecan-1 in the pathogenesis of coronavirus disease 2019 (COVID-19)","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2021.107684","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107684"}}